Pharsight

Drugs that contain Asenapine

1. Secuado patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11123305 HISAMITSU Patch
Jul, 2033

(9 years from now)

US10583121 HISAMITSU Patch
Jul, 2033

(9 years from now)

US10814002 HISAMITSU Patch and method for producing the same
Jul, 2033

(9 years from now)

US9687474 HISAMITSU Patch
Jul, 2033

(9 years from now)

US10022445 HISAMITSU Patch
Jul, 2033

(9 years from now)

US11813364 HISAMITSU Patch
Sep, 2033

(9 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Oct 11, 2022

Market Authorisation Date: 11 October, 2019

Treatment: Method of treating adults with schizophrenia comprising administering asenapine via a transdermal patch

Dosage: SYSTEM;TRANSDERMAL

More Information on Dosage

SECUADO family patents

Family Patents